In February 2009, against Andrew Witty on his vision for Big Pharma as a catalyst for change, focus on two key issues: 1) the promotion of innovation in products for the prevention or treatment of neglected tropical diseases, and 2) improving access to medicines in the poorest world countries. He announced the creation of the “Pharmaceutical patent pool” and wondered if it was delivered to the two central questions the right strategy.

In February 2009, against Andrew Witty on his vision for Big Pharma as a catalyst for change, focus on two key issues: 1) the promotion of innovation in products for the prevention or treatment of neglected tropical diseases, and 2) improving access to medicines in the poorest world countries. He announced the creation of the “Pharmaceutical patent pool” and wondered if it was delivered to the two central questions the right strategy.
«Hide

from
Michael Rouse,
Chander Sehgal
Source: Ivey Publishing
20 pages.
Release Date: 8 March 2011. Prod #: W10017-PDF-ENG
GSK Andrew Witty: Addressing Neglected Tropical Diseases and Global Health Issues – The “Pharmaceutical patent pool” (A) HBR case solution